Cellectar Biosciences Inc
CLRB
Market Cap$364.03M
Close$
$0.61
92.2% downside
Current Fair Value
92.2% downsideOvervalued by 92.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $364.03 Million |
|---|---|
| Enterprise Value | $350.60 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.22 |
| Beta | 0.52 |
| Outstanding Shares | 46,079,875 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -14.83 |
|---|---|
| PEG | 21.37 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -7.58 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Cellectar Biosciences Inc
CEO: James Caruso